Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC HEPATITIS B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01804387
What this trial is testing

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study

Who this might be right for
Chronic Hepatitis B
Korea University 60
Post-approval studies (Phase 4)Study completedNCT02339337
What this trial is testing

A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection

Who this might be right for
HBV/HCV Co-infection
Kaohsiung Medical University Chung-Ho Memorial Hospital 203
Post-approval studies (Phase 4)UnknownNCT02327702
What this trial is testing

Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, ChronicPregnancy
Asian-Pacific Alliance of Liver Disease, Beijing 200
Early research (Phase 1)Ended earlyNCT03032536
What this trial is testing

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

Who this might be right for
Hepatitis BChronic Hepatitis BViral Hepatitis B
Alios Biopharma Inc. 54
Not applicableStudy completedNCT01531166
What this trial is testing

A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon

Who this might be right for
Chronic Hepatitis B
Yonsei University 500
Not applicableStudy completedNCT03373396
What this trial is testing

Impact of Chlordecone on Active Chronic Hepatitis

Who this might be right for
Fibrosis, Liver
Centre Hospitalier Universitaire de la Guadeloupe 283
Not applicableUnknownNCT00063596
What this trial is testing

Vitamin A Supplementation in Preterm Infants

Who this might be right for
Infant, Premature
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 220
Not applicableUnknownNCT03559790
What this trial is testing

Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea

Who this might be right for
Chronic Hepatitis b
The Catholic University of Korea 400
Post-approval studies (Phase 4)Study completedNCT00558818
What this trial is testing

Long-term Study With Clevudine

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 150
Early research (Phase 1)Ended earlyNCT02826018
What this trial is testing

ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis BChronic Hepatitis BHepatitis B, Chronic+2 more
Alnylam Pharmaceuticals 24
Testing effectiveness (Phase 2)Looking for participantsNCT07137910
What this trial is testing

Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 200
Post-approval studies (Phase 4)Ended earlyNCT01627223
What this trial is testing

Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation

Who this might be right for
Chronic Hepatitis B
Taichung Veterans General Hospital 17
Large-scale testing (Phase 3)Study completedNCT00686790
What this trial is testing

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
Merck Sharp & Dohme LLC 68
Not applicableStudy completedNCT01267162
What this trial is testing

Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients

Who this might be right for
Chronic Hepatitis B
Medical Procare PLLC 31
Large-scale testing (Phase 3)Study completedNCT02792088
What this trial is testing

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues

Who this might be right for
Chronic Hepatitis B
IlDong Pharmaceutical Co Ltd 146
Post-approval studies (Phase 4)UnknownNCT05382013
What this trial is testing

Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

Who this might be right for
ThrombocytopeniaHepatitis B, ChronicAcute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University 60
Not applicableStudy completedNCT01471535
What this trial is testing

HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 20
Not applicableLooking for participantsNCT07491848
What this trial is testing

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

Who this might be right for
HEPATITIS B CHRONICHepatitis DPeriodontitis
Research Center of Periodontal-Systemic Interactions 25
Not applicableStudy completedNCT00158717
What this trial is testing

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

Who this might be right for
Hepatitis B
Gilead Sciences 107
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Next Page